NASDAQ:CLRB - Nasdaq - US15117F8077 - Common Stock - Currency: USD
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 51.78M | 38.96M | 28.81M | 24.13M | 15.30M | |||
Research and Development | 26.14M | 27.27M | 19.22M | 17.59M | 10.14M | |||
Selling, General, and Administrative Expenses | 25.64M | 11.69M | 9.59M | 6.54M | 5.15M | |||
Operating Income | -51.78M | -38.96M | -28.81M | -24.13M | -15.30M | |||
Interest Income/Expense | 7.26M | -3.87M | 150.00K | 0.00 | 10.00K | |||
Other Income/Expense | N/A | N/A | 0.00 | 10.00K | N/A | |||
Non Recurring Items | N/A | N/A | N/A | 0.00 | 190.00K | |||
Income Before Taxes | -44.52M | -42.83M | -28.66M | -24.12M | -15.09M | |||
Income Tax | 66.00K | -60.00K | -60.00K | 0.00 | 0.00 | |||
Net Income | -44.58M | -42.77M | -28.60M | -24.12M | -15.09M | |||
EBITDA | -51.49M | -38.77M | -28.66M | -23.98M | -15.16M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.22 | -3.50 | -4.05 | -4.35 | -7.62 | |||
Non GAAP EPS | -1.23 | -2.93 | -4.05 | -4.30 | -9.00 | |||
Statistics |
All data in USD